Live Chat
Send Offline Message

Fildena CT 50

Fildena CT 50
Fortune Health Care
Brand: Fortune Health Care
Availability: In Stock
* Packages:
Upload Prescription:
Upload File

Rating : 3 reviews

To treat Erectile Dysfunction or impotency in men Fildena CT 50 is safe and effective. This tablet contains a very high-quality Sildenafil, which is the main component of this medicine. Fortune Healthcare Pvt Ltd which is one of the leading Pharmaceutical company has manufactured this medicine.

Active Ingredient:

This medicine contains Sildenafil Citrate which helps improve blood flow to the penile region to produce an erection. This medicine is safe and effective in treating erectile dysfunction. This relaxes muscles and blood vessels so the blood flow to erectile problems is increased for an erection. With the presence of sexual intercourse, the effectiveness of this drug will work effectively.


Fildena CT 50 helps a man to attain a proper and stiffer erection of penile for a longer time so that he can able gratify his sensual needs as well as satisfy his spouse. To increase the erection time by relieving men from stress and relaxing smooth muscles around the penile is the basic function of this medicine.

The effectiveness of taking this medicine can last up to 4 hours after taking the pill. The intake of this medicine must be in the right proportion for men to enjoy complete sexual satisfaction, despite erectile dysfunction.


Fildena CT 50 is a chewable form of a tablet that can be consumed before 1 hour to 30 minutes of sexual intercourse. Make sure that you don’t consume this medicine more than once per day.

Overconsumption of this pill may lead to severe side effects in men. Take this medicine only as directed by your healthcare professional or doctors. It is not recommended for women or children below 18 years of age.


Write a review

Your Name:

Your Review:

Note: HTML is not translated!

Rating: Bad            Good

Enter the code in the box below:

Live Chat
Send Offline Message
Logos and trademarks remain the property of the corresponding companies. © 2021